It has been reported that EGF stimulation of ERK is enhanced in Rat-1 cells treated with MβCD55, but in contrast MβCD treatment alone has been shown to suppress ERK activation in human breast cancer cells56. This evidence concerns the gene EGF and breast carcinoma.